MWVC
RETA

Morgens Waterfall Vintiadis & Co’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-20,000
Closed -$3.12M 35
2020
Q2
$3.12M Buy
20,000
+14,000
+233% +$2.18M 2.01% 23
2020
Q1
$866K Sell
6,000
-22,600
-79% -$3.26M 0.81% 27
2019
Q4
$5.85M Sell
28,600
-9,400
-25% -$1.92M 3.97% 4
2019
Q3
$3.05M Buy
38,000
+3,650
+11% +$293K 2.34% 22
2019
Q2
$3.24M Buy
34,350
+2,350
+7% +$222K 2.23% 23
2019
Q1
$2.74M Hold
32,000
1.96% 25
2018
Q4
$1.8M Hold
32,000
1.6% 29
2018
Q3
$2.62M Sell
32,000
-8,000
-20% -$654K 1.71% 27
2018
Q2
$1.4M Buy
+40,000
New +$1.4M 0.99% 31